Media, Sera and Reagents Market to see 6.0% Annual Growth Through 2023
July 26, 2018
WELLESLEY, Mass., July 26, 2018–Growing demand for cell culture products for the production of biologics and biosimilars and the expansion of cell cultures across a wide array of applications are factors helping to boost global growth of the media, sera and reagents market, according to a report by BCC Research.
The industry expects to see a compound annual growth rate (CAGR) of 6.0% through 2023, when it could be worth $5.5 billion, according to the report Global Markets for Media, Sera and Reagents in Biotechnology.
Major players in the market include Thermo Fisher Scientific, Merck GE Healthcare, Corning, Lonza and BD Bioscience.
Research Highlights
- Reagents will lead the market by size and growth, with a 2023 estimated value of $2.4 billion and a CAGR through the period of 6.5%. Media will have a 2023 value of $2.1 billion and a CAGR of 6.3%.
- Production will lead end users with a 2023 value of $3.1 billion and a CAGR of 6.4%, followed by research at $1.7 billion and a CAGR of 5.8%.
- Growth will be led by the Asia-Pacific region, with a CAGR through 2023 of 7.6%, while North America will lead the market by size, with a 2023 estimated value of $2.4 billion.
“Media, sera and reagents provide favorable environmental conditions for the in vitro growth of cells,” the report notes. “Technological developments coupled with innovative product launches of media for cell cultures, such as chemically-defined media/serum-free media and culture media based on advanced granulation technology, are likely to increase productivity with reduced costs and drive the cell culture media market in coming years.”
Market Restraints Include Ethical Issues, Regulatory Constraints and a Lack of Skilled Technicians
A number of factors are combining to restrain growth in the market, the report adds. Chief among those are ethical issues, which include consent, destruction of embryos and conflicting legal standards. The industry is subject to a host of regulatory guidelines as well, including the necessity that researchers submit proposals to government agencies. Further, the industry’s growth in emerging markets such as India is straining local talent pools, which lack sufficient numbers of skilled technicians to culture cells under in vitro conditions.
Editors/reporters requesting analyst interviews should contact Eric Surber at press@bccresearch.com.
Global Markets for Media, Sera and Reagents in Biotechnology( BIO014K )
Publish Date: Jul 2018
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.
BCC Library Membership Benefits
Unlimited Access to Market Research Reports for Academic Institutions and Corporations.
Custom Research
Tailored solutions across industries for your unique business needs.
More in Cell Biology
- Biomarker Deals Accelerate: Strategic Alliances Reshape Life Sciences Innovation
- China’s DNA Sequencing Market to Grow at 21.5% CAGR by 2030
- mRNA Market Forecast: Small Decline of -0.04% CAGR by 2030
- Molecular Diagnostics Market to Grow at 13.1% CAGR Through 2030
- Biotech Equipment Market Projected to Reach $143.9 Billion Globally by 2030
Reports from Cell Biology
Recent News
- Global Hyaluronic Acid in Healthcare Market to Reach $10.5 Billion by 2030
- Global Patient Monitoring Market to Reach $55.8 Billion by End of 2030
- Global Market for Biological and Medical Imaging Reagents Set to Surge to $40.1 Billion by 2030
- Targeted Alpha Therapies Market to Grow at 44% CAGR Globally by 2030
- Global Anti-Parkinson's Drugs Markets Projected to Reach $9.2 Billion by the End of 2030
